Internal Medicine, Endocrinology, Diabetes, & Metabolism · Wichita, KS
NPI
1952564908
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
8110 E 32nd St N Ste 125
Wichita, KS, 67226
Phone (316) 330-3636
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
3,832 services
Medicare patients, 2024
1,161
Average age 72
Drug cost, 2024
$5.8M
14,550 prescriptions
Company payments, 2025
$1,661
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Georges Elhomsy was code 99214 (office e&m - established), 1,158 times for 793 patients. In total Georges Elhomsy billed 3,832 services in 28 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,158 | 793 | $82.63 | $96K |
| 95251 Test - Miscellaneous | Office | 449 | 249 | $24.07 | $11K |
| 83036 Blood Count | Office | 380 | 267 | $9.35 | $3,553 |
| 76536 Ultrasound - Nonspecific | Office | 202 | 192 | $66.92 | $14K |
| 99204 Office E&M - New | Office | 155 | 155 | $104.14 | $16K |
| 99213 Office E&M - Established | Office | 153 | 148 | $56.56 | $8,653 |
| 96372 Injection Administration | Office | 58 | 27 | $9.56 | $554 |
| 10005 Other Organ Systems | Office | 49 | 48 | $94.70 | $4,640 |
| 99215 Office E&M - Established | Office | 42 | 40 | $107.01 | $4,495 |
| 99203 Office E&M - New | Office | 40 | 40 | $71.39 | $2,856 |
| J0834 Injection, cosyntropin, 0.25 mg | Office | 14 | 13 | $19.25 | $269 |
| 99211 Office E&M - Established | Office | 13 | 12 | $13.18 | $171 |
| 99205 Office E&M - New | Office | 11 | 11 | $164.03 | $1,804 |
| 10006 Other Organ Systems | Office | 11 | 11 | $44.76 | $492 |
By year: 2022 $148K for 21,765 services; 2023 $156K for 6,521 services; 2024 $165K for 3,832 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 380 | 267 | $9.35 | $3,553 |
Medicare prescription drug claims, 2024
In 2024, the drug Georges Elhomsy prescribed most often to Medicare patients was Levothyroxine Sodium, with 2,322 prescriptions and refills. In total Georges Elhomsy wrote 14,550 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 2,322 | 4,694 | 495 | $15K |
| Ozempic Semaglutide | 1,024 | 1,245 | 197 | $1.2M |
| Liothyronine Sodium Generic | 947 | 1,786 | 201 | $22K |
| Mounjaro Tirzepatide | 812 | 949 | 157 | $986K |
| Synthroid Levothyroxine Sodium | 763 | 1,283 | 134 | $57K |
| Metformin Hcl Er Metformin Hcl | 637 | 1,528 | 174 | $4,585 |
| Glimepiride Generic | 561 | 1,331 | 161 | $2,982 |
| Rosuvastatin Calcium Generic | 470 | 1,115 | 127 | $3,803 |
| Methimazole Generic | 319 | 622 | 76 | $1,912 |
| Metformin Hcl Generic | 318 | 744 | 85 | $2,034 |
| Atorvastatin Calcium Generic | 309 | 804 | 84 | $1,523 |
| Tresiba Flextouch U-200 Insulin Degludec | 306 | 559 | 76 | $355K |
| Jardiance Empagliflozin | 293 | 469 | 63 | $267K |
| Alendronate Sodium Generic | 230 | 470 | 61 | $1,161 |
| Novolog Flexpen Insulin Aspart | 213 | 333 | 61 | $45K |
Brand drugs: 6,996 claims; generic drugs: 7,159 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Georges Elhomsy $1,661 ($1,661 in general payments such as food, travel and fees) from 22 companies. The largest payer was Chiesi USA, Inc. with $350.
| Company | Payments | Amount |
|---|---|---|
| Chiesi USA, Inc. | 3 | $350 |
| Insulet Corporation PODD | 38 | $250 |
| Recordati_rare_diseases_inc. | 7 | $164 |
| Amgen Inc. AMGN | 11 | $159 |
| Medtronic, Inc. MDT | 6 | $155 |
| Corcept Therapeutics CORT | 6 | $107 |
| Dexcom, Inc. DXCM | 3 | $72.53 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $55.34 |
| Novo Nordisk Inc NVO | 3 | $45.51 |
| Antares Pharma, Inc. | 2 | $42.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.